- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/00 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 249/00
Total number of patents in this class: 74
10-year publication summary
|
3
|
2
|
3
|
3
|
2
|
2
|
3
|
3
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4877 |
9 |
| The Regents of the University of California | 19608 |
2 |
| Merck Sharp & Dohme Corp. | 2214 |
2 |
| Bayer Cropscience AG | 2131 |
2 |
| ChemoCentryx, Inc. | 392 |
2 |
| Dipharma Francis S.r.l. | 48 |
2 |
| Rigel Pharmaceuticals, Inc. | 586 |
2 |
| Synta Pharmaceuticals Corp. | 188 |
2 |
| Merck Sharp & Dohme LLC | 3755 |
2 |
| Novartis AG | 11229 |
1 |
| Hoffmann-La Roche Inc. | 3303 |
1 |
| Merck & Co., Inc. | 425 |
1 |
| Boehringer Ingelheim International GmbH | 4754 |
1 |
| Syngenta Limited | 481 |
1 |
| Amgen Inc. | 3918 |
1 |
| BASF AG | 679 |
1 |
| Konica Minolta Business Technologies, Inc. | 1461 |
1 |
| Siemens Medical Solutions USA, Inc. | 1522 |
1 |
| The General Hospital Corporation | 4659 |
1 |
| President and Fellows of Harvard College | 5918 |
1 |
| Other owners | 38 |